PAR 0.00% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM PROVIDES IND APPLICATION UPDATE, page-24

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    Could be 90 days. The FDA will likely need 30 days to review the answers. Depends how quickly the FDA get the questions to PAR, how quickly PAR get them back to the FDA, and then the FDA have to review those answers.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.